World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
77
Citations
25710
World Ranking
4715
National Ranking
2284

Research.com Recognitions

  • 2019 - ACM Distinguished Member
  • 2018 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2017 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2006 - Fellow of Alfred P. Sloan Foundation
  • 1963 - Fellow of John Simon Guggenheim Memorial Foundation

Overview

Jeffrey A. Johnson is affiliated with the University of Wisconsin-Madison in the United States. Their research primarily spans the field of Medicine with a focus on several subfields, including Infectious Diseases, Virology, Molecular Biology, Epidemiology, and Endocrinology, Diabetes and Metabolism.

Their work covers multiple topics, with a strong emphasis on HIV research and treatment, including interventions and drug development. In addition, work relating to SARS-CoV-2 and COVID-19 has been a significant area of focus, addressing detection, testing, and clinical research studies. Other topics include mechanisms related to neuroinflammation and neurodegeneration.

Among their recent papers are the following:

  • Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020 (2020, JAMA Internal Medicine)
  • SARS-CoV-2 Infections and Serologic Responses from a Sample of U.S. Navy Service Members - USS Theodore Roosevelt, April 2020 (2020, MMWR Morbidity and Mortality Weekly Report)
  • Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology (2022, Nature Communications)
  • Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020 (2020, MMWR Morbidity and Mortality Weekly Report)
  • Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration (2023, Nature Communications)

Frequent co-authors associated with their work include:

  • S. Michele Owen
  • Silvina Masciotra
  • Natalie J. Thornburg
  • Brandi Freeman
  • Sandra Lester

Their publications are commonly found in journals such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • MMWR Morbidity and Mortality Weekly Report
  • Nature Communications
  • Viruses
  • Journal of Clinical Virology

Jeffrey A. Johnson has received several awards over the course of their career. These include recognition as an ACM Distinguished Member in 2019 and multiple fellowships, including the American Association for the Advancement of Science (AAAS) in 2017 and 2018, fellowship of the Alfred P. Sloan Foundation in 2006, and fellowship of the John Simon Guggenheim Memorial Foundation in 1963.

Best Publications

  • Identification of the NF-E2-related Factor-2-dependent Genes Conferring Protection against Oxidative Stress in Primary Cortical Astrocytes Using Oligonucleotide Microarray Analysis

    Jong-Min Lee;Marcus J. Calkins;Kaimin Chan;Yuet Wai Kan

  • Coordinate Regulation of Glutathione Biosynthesis and Release by Nrf2-Expressing Glia Potently Protects Neurons from Oxidative Stress

    Andy Y. Shih;Delinda A. Johnson;Gloria Wong;Andrew D. Kraft

  • The Nrf2–ARE Pathway

    Jeffrey A. Johnson;Delinda A. Johnson;Andrew D. Kraft;Marcus J. Calkins

  • Nuclear Factor E2-Related Factor 2-Dependent Antioxidant Response Element Activation by tert-Butylhydroquinone and Sulforaphane Occurring Preferentially in Astrocytes Conditions Neurons against Oxidative Insult

    Andrew D. Kraft;Delinda A. Johnson;Jeffrey A. Johnson

  • Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease : Critical role for the astrocyte

    Pei Chun Chen;Marcelo R. Vargas;Amar K. Pani;Richard J. Smeyne

  • Nrf2, a multi-organ protector?

    Jong Min Lee;Jiang Li;Delinda A. Johnson;Thor D. Stein

  • The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease

    Marcus J. Calkins;Delinda A. Johnson;Jessica A. Townsend;Marcelo R. Vargas

  • Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis.

    Marcelo R. Vargas;Delinda A. Johnson;Daniel W. Sirkis;Albee Messing

  • Inhibition of 7,12-Dimethylbenz(a)anthracene- and N-Nitrosomethylurea-induced Rat Mammary Cancer by Dietary Flavonol Quercetin

    Ajit K. Verma;Jeffrey A. Johnson;Michael N. Gould;Martin A. Tanner

  • Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways.

    Thor D. Stein;Jeffrey A. Johnson

  • Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis.

    Thor D. Stein;Nicholas J. Anders;Charles DeCarli;Sic L. Chan

  • NF-E2-related Factor-2 Mediates Neuroprotection against Mitochondrial Complex I Inhibitors and Increased Concentrations of Intracellular Calcium in Primary Cortical Neurons

    Jong-Min Lee;Andy Y. Shih;Timothy H. Murphy;Jeffrey A. Johnson

  • Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

    Delinda A. Johnson;Jeffrey A. Johnson

  • The Nrf2-ARE cytoprotective pathway in astrocytes.

    Marcelo R. Vargas;Jeffrey A. Johnson

  • Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription

    Marcus J. Calkins;Rebekah J. Jakel;Delinda A. Johnson;Kaimin Chan

  • Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes

    Melinda S. Yates;Masafumi Tauchi;Fumiki Katsuoka;Kathleen C. Flanders

  • Phosphatidylinositol 3-Kinase, Not Extracellular Signal-regulated Kinase, Regulates Activation of the Antioxidant-Responsive Element in IMR-32 Human Neuroblastoma Cells

    Jong-Min Lee;Janean M. Hanson;Waihei A. Chu;Jeffrey A. Johnson

  • Nrf2-mediated protection against 6-hydroxydopamine.

    Rebekah J. Jakel;Jessica A. Townsend;Andrew D. Kraft;Jeffrey A. Johnson

  • Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells.

    Jiang Li;Delinda Johnson;Marcus Calkins;Lynda Wright

  • Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases.

    Li Gan;Jeffrey A. Johnson

Frequent Co-Authors

Sabine Werner
Sabine Werner ETH Zurich
Yuet Wai Kan
Yuet Wai Kan University of California, San Francisco
Albee Messing
Albee Messing University of Wisconsin–Madison
Laurence G. Rahme
Laurence G. Rahme Harvard University
Mark P. Mattson
Mark P. Mattson Johns Hopkins University
Ronald W. Davis
Ronald W. Davis Stanford University
Mehmet Toner
Mehmet Toner Harvard University
Michael N. Mindrinos
Michael N. Mindrinos Stanford University
Wenzhong Xiao
Wenzhong Xiao Harvard University
Timothy H. Murphy
Timothy H. Murphy University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Jeffrey A. Johnson

Trending Scientists

Recently Published Articles